| Literature DB >> 26132628 |
Gisela Nogales-Gadea1, Abhishek Saxena2, Carolin Hoffmann2, Judith Hounjet2, Daniëlle Coenen2, Peter Molenaar2, Mario Losen2, Pilar Martinez-Martinez3.
Abstract
Finding new methods for generating human monoclonal antibodies is an active research field that is important for both basic and applied sciences, including the development of immunotherapeutics. However, the techniques to identify and produce such antibodies tend to be arduous and sometimes the heavy and light chain pair of the antibodies are dissociated. Here, we describe a relatively simple, straightforward protocol to produce human recombinant monoclonal antibodies from human peripheral blood mononuclear cells using immortalization with Epstein-Barr Virus (EBV) and Toll-like receptor 9 activation. With an adequate staining, B cells producing antibodies can be isolated for subsequent immortalization and clonal expansion. The antibody transcripts produced by the immortalized B cell clones can be amplified by PCR, sequenced as corresponding heavy and light chain pairs and cloned into immunoglobulin expression vectors. The antibodies obtained with this technique can be powerful tools to study relevant human immune responses, including autoimmunity, and create the basis for new therapeutics.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26132628 PMCID: PMC4545184 DOI: 10.3791/52830
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355